OAU Researcher Secures $5 Million Grant for Project Targeting 60% Reduction in Nigeria’s Maternal Deaths

By Simpson Global Media News Desk

ILE-IFE, Osun State — Obafemi Awolowo University researcher Professor Ibraheem O. Awowole has secured a US$5 million Gates Foundation-funded grant for a three-year initiative designed to improve pregnancy care and target a 60 per cent reduction in maternal deaths in Nigeria.

The project, known as Pregnancy Risk Stratification Innovations in Maternal Health (PRIME), will be led by Obafemi Awolowo University (OAU), Ile-Ife, in partnership with Jhpiego, the Federal Ministry of Health and Social Welfare, and the ministries of health in seven states.

According to an announcement published by OAU on October 10, the initial implementation states are Lagos, Ogun, Ekiti, Kano, Kaduna, Gombe and Jigawa.

The initiative will focus on identifying pregnant women who face a higher risk of life-threatening complications and improving the chances that they receive appropriate care early enough to prevent avoidable deaths.

The university said the programme seeks to address a major public health challenge in Nigeria, where pregnancy and childbirth complications continue to place a heavy burden on women, families and healthcare services.

The 60 per cent figure is the project's stated target, not an already achieved reduction. Its eventual impact will depend on implementation, the quality of screening and clinical care, access to treatment, and the ability of participating health systems to respond when risks are identified.

The announcement adds to a series of efforts by Nigerian institutions and international partners to strengthen maternal healthcare through research, earlier intervention and better coordination between community-level services and hospitals.

Why identifying high-risk pregnancies matters

Pregnancy is a normal biological process, but some women develop complications that can threaten their lives or the lives of their babies. Certain conditions can worsen rapidly if warning signs are not recognised and appropriate treatment is delayed.

One important example is pre-eclampsia, a pregnancy-related condition involving high blood pressure that can lead to serious complications affecting the mother and baby. Other major causes of maternal illness and death include severe bleeding, infections and complications associated with childbirth.

Some risks can be identified during antenatal appointments through clinical assessments, blood-pressure measurements, medical history and other appropriate examinations. Screening, however, is only one part of the process. Women who show warning signs must also be able to access further assessment, treatment and emergency referral when necessary.

The PRIME initiative is intended to strengthen this chain of care by improving the identification of women who may need additional attention.

At the announcement of the grant, OAU College of Health Sciences Provost Professor Bernice Adegbehingbe highlighted the importance of detecting pregnancy complications early, particularly pre-eclampsia.

Her comments underline a central challenge in maternal health: a warning sign can only save a life if a healthcare worker identifies it, understands its significance and has the means to act.

For women living far from well-equipped facilities, the distance between screening and treatment can be particularly consequential. Transport difficulties, treatment costs, shortages of trained personnel and delays in referral can all undermine efforts to prevent avoidable deaths.

A programme that improves risk assessment must therefore work alongside reliable clinical services, functioning referral arrangements and access to emergency obstetric care.

Seven states selected for the initial phase

The PRIME project will initially operate in seven states: Lagos, Ogun, Ekiti, Kano, Kaduna, Gombe and Jigawa.

The selection provides an opportunity to implement the intervention across different health-system environments, populations and service-delivery conditions. However, the announcement does not establish that every local government area or healthcare facility in the seven states will participate.

The programme's precise geographic coverage, number of participating facilities, screening targets and rollout timetable will be important details to watch as implementation progresses.

The participating state ministries of health are expected to be important partners in translating the initiative into services that work within their local healthcare systems. Their role will matter for coordination with hospitals, primary healthcare facilities, antenatal services and referral networks.

The Federal Ministry of Health and Social Welfare will also be involved, linking the project to Nigeria's wider maternal-health priorities.

OAU's leadership provides a research and academic base for the initiative, while Jhpiego brings experience in maternal and reproductive health programmes. The collaboration combines research, public-sector coordination and implementation support.

The announcement did not provide a detailed state-by-state breakdown of the grant or the amount allocated to each partner. Those figures should not be assumed without further disclosure.

What pregnancy risk stratification means

Risk stratification is the process of assessing available information to determine which individuals may face a greater likelihood of a particular health problem.

In maternal healthcare, it can help clinicians identify women who require closer monitoring, further investigations, specialist attention or a more carefully planned delivery and referral pathway.

The assessment may take account of factors such as a woman's medical and obstetric history, current symptoms, blood pressure and findings from clinical examinations. The appropriate assessment depends on established clinical guidance and the circumstances of each pregnancy.

Risk assessment is not a guarantee that a complication will or will not occur. Some women who appear to have low risk may still develop emergencies, while many women identified as higher risk can have healthy pregnancies with suitable monitoring and care.

For that reason, risk stratification should complement—not replace—regular antenatal care, clinical judgement and access to emergency services.

The value of PRIME will depend on whether its approach helps health workers identify risks accurately, prioritise follow-up and connect women with the care they need.

It will also be important to ensure that screening does not create unnecessary barriers for women who have difficulty reaching facilities. If risk identification leads to additional appointments, tests or referrals, the healthcare system must be prepared to provide those services without imposing unaffordable costs or excessive travel demands on families.

A major maternal-health challenge for Nigeria

Nigeria faces a substantial maternal mortality burden. OAU's announcement described the country as accounting for approximately one-quarter of maternal deaths worldwide, illustrating the scale of the challenge the project is intended to address.

Maternal mortality is influenced by a combination of clinical, economic and health-system factors. A woman's outcome can depend not only on the complication she develops, but also on whether she receives antenatal care, whether danger signs are recognised, how quickly she reaches an appropriate facility and whether that facility has the staff, medicines, blood supplies and equipment needed to provide treatment.

The quality and continuity of care before, during and after childbirth are therefore critical.

The World Health Organization has repeatedly emphasised the importance of skilled care throughout pregnancy and childbirth, as well as timely access to emergency obstetric services. Preventing deaths requires interventions that reach women before complications become critical and health facilities that can respond when emergencies occur.

For Nigeria, the challenge is particularly demanding because access to services varies across communities. Women in rural and underserved areas may face long journeys to health facilities, while financial pressures and other social barriers can discourage or delay care-seeking.

Improving screening and risk identification can contribute to better outcomes, but it cannot by itself resolve these broader problems.

The project's progress will need to be judged against measurable results, including whether women at higher risk are identified earlier, whether referrals are completed, whether treatment is delivered promptly and whether maternal complications and deaths decline.

Why pre-eclampsia deserves attention

Pre-eclampsia is one of the pregnancy complications highlighted in the university's announcement.

The condition usually develops after 20 weeks of pregnancy and is associated with high blood pressure and signs that organs may be affected. It can become dangerous for both the mother and baby if it is not recognised and managed appropriately.

Possible warning signs can include severe or persistent headaches, visual disturbances, severe pain below the ribs, sudden swelling of the face or hands, or feeling very unwell. Some women may have no obvious symptoms, which is one reason routine antenatal checks are important.

Anyone experiencing potentially serious symptoms during pregnancy should seek urgent medical assessment rather than wait for a scheduled appointment. Symptoms alone cannot confirm or exclude pre-eclampsia; clinical evaluation is necessary.

Depending on the severity and stage of pregnancy, management may require close monitoring, medication, hospital admission or delivery. The appropriate course must be determined by qualified healthcare professionals.

The emphasis on early identification in the PRIME announcement reflects the need to detect concerning changes before they progress to life-threatening complications.

However, screening has the greatest value when it is connected to a clear response plan. Health workers must be able to arrange follow-up assessments, explain the findings to patients and refer women to facilities capable of providing the required level of care.

The role of research in improving clinical practice

The PRIME award places a Nigerian university researcher at the centre of a project addressing a major national health concern.

Universities can contribute to health-system improvement by studying which interventions work, identifying obstacles to implementation and evaluating whether services produce the intended results in real-world settings.

Research-led programmes can also help governments determine how limited resources should be used. For example, reliable evidence may show which screening approaches are practical in primary healthcare facilities, what training frontline workers need and which referral arrangements are most effective.

The challenge is to translate research findings into routine care. A promising intervention can have limited impact if health workers are not adequately trained, equipment is unavailable or facilities cannot provide treatment after a risk is identified.

That is why partnerships between universities, government health authorities and implementation organisations can be important. They create opportunities to link evidence with policy and frontline service delivery.

For PRIME, the three-year implementation period should provide an opportunity to assess how its approach works across the seven participating states. Public reporting on methods, progress and outcomes will help clinicians, policymakers and other researchers understand whether the programme is achieving its aims.

The announcement does not yet provide a detailed evaluation framework or interim milestones. Information on those elements will be important for assessing the project's performance as it develops.

Funding is important, but delivery will determine the impact

The US$5 million grant represents a significant investment in a programme designed to address maternal health. But funding alone does not guarantee a reduction in deaths.

Successful implementation will require a clear plan for deploying resources, supporting participating facilities, training personnel and monitoring results.

It will also require attention to the practical realities faced by pregnant women. A woman identified as high risk may still be unable to benefit if she cannot afford transport to a referral hospital, if the facility lacks essential supplies or if emergency treatment is not available when she arrives.

The programme's partners will need to consider how risk assessment fits into existing antenatal and maternity services, rather than creating a separate process that is difficult for healthcare workers or patients to navigate.

Reliable data will be equally important. Recording the number of women screened, the risks identified, referrals made and completed, complications treated and outcomes achieved can help determine whether the project is improving care.

The information can also help identify gaps. If women are screened but cannot reach referral facilities, the problem may lie beyond the screening process. If complications are identified but treatment is delayed, the response may require better staffing, supplies or emergency arrangements.

These are the kinds of practical questions that implementation and evaluation should help answer.

Linking the initiative to Nigeria's wider health reforms

The PRIME grant comes amid wider efforts to improve maternal and newborn healthcare in Nigeria.

In September 2026, the Gates Foundation and MTN Group Foundation announced the Nigeria Maternal Health Multiplier, a separate initiative intended to expand access to maternal healthcare through digital tools, connectivity and support for frontline health workers.

That programme aims by 2030 to help 500,000 women access higher-quality maternal care, equip 5,000 frontline health workers with tools to identify complications and support 500 health facilities.

The Maternal Health Multiplier and PRIME are distinct initiatives with different announced structures and targets. They should not be treated as a single programme. Their shared emphasis on earlier identification and stronger frontline care nevertheless reflects a broader effort to improve how maternal-health risks are detected and managed.

Digital tools can support healthcare workers by helping them access guidance, record information and identify when further assessment may be necessary. But technology must be designed around clinical needs, reliable connectivity and the realities of the facilities where it is used.

It must also protect patient privacy and operate as a support for trained healthcare professionals, not as a substitute for medical examination or emergency treatment.

The wider objective is to build a system in which women can receive appropriate care throughout pregnancy, childbirth and the postnatal period, regardless of where they live.

What success should look like

The project's stated ambition to reduce maternal deaths by 60 per cent is substantial. Determining whether it is achieved will require transparent reporting and a clear understanding of how results are measured.

Useful indicators could include the proportion of pregnant women receiving timely antenatal assessments, the number of women whose risk factors are identified, the time taken to complete referrals and the availability of appropriate treatment at receiving facilities.

Researchers will also need to distinguish between improvements in identifying risk and improvements in health outcomes. More cases being detected at the beginning of a programme can reflect better screening rather than a worsening of underlying health conditions.

Similarly, changes in maternal deaths must be interpreted carefully, with attention to the number of births, the characteristics of the population served, the period of observation and other interventions operating at the same time.

The public should be able to see how the project defines its baseline, how progress is tracked and how the final results compare with the target.

Such transparency would help determine whether the programme's methods could be expanded to other parts of Nigeria or adapted for different health-system settings.

Looking ahead

Professor Awowole's US$5 million grant places PRIME among the latest efforts to address Nigeria's maternal-health challenges through research and practical intervention.

The project will initially operate in Lagos, Ogun, Ekiti, Kano, Kaduna, Gombe and Jigawa, with OAU leading implementation alongside Jhpiego, federal health authorities and participating state ministries.

Its central aim is to identify women at higher risk of serious pregnancy complications earlier and improve their access to appropriate care. The announced target of reducing maternal deaths by 60 per cent remains an objective that must be tested through implementation and evidence.

For pregnant women and their families, the ultimate measure of success will not be the size of the grant or the ambition of the target. It will be whether warning signs are recognised sooner, referrals lead to timely treatment and fewer women die from complications that healthcare systems can prevent or manage.

As the programme moves forward, clear reporting on its rollout, resources and outcomes will be essential to showing whether the investment is translating into safer pregnancies and childbirth across the participating states.

Sources and further information

• Obafemi Awolowo University — Official announcement of the US$5 million PRIME grant

• Gazette Nigeria — OAU researcher secures $5 million grant to reduce maternal deaths

• Gates Foundation — Nigeria Maternal Health Multiplier announcement

• World Health Organization — Maternal health